208 related articles for article (PubMed ID: 30560448)
1. Hemolytic uremic syndrome associated with Bordetella pertussis infection in a 2-month-old infant carrying a pathogenic variant in complement factor H.
Madden I; Roumenina LT; Langlois-Meurinne H; Guichoux J; Llanas B; Frémeaux-Bacchi V; Harambat J; Godron-Dubrasquet A
Pediatr Nephrol; 2019 Mar; 34(3):533-537. PubMed ID: 30560448
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hemolytic uremic syndrome related to Bordetella pertussis infection -is plasma exchange or eculizumab use necessary?
Saida K; Ogura M; Kano Y; Ishimori S; Yoshikawa T; Nagata H; Sato M; Kamei K; Ishikura K
BMC Nephrol; 2018 Dec; 19(1):365. PubMed ID: 30558570
[TBL] [Abstract][Full Text] [Related]
3. Hemolytic uremic syndrome caused by Bordetella pertussis infection.
Chaturvedi S; Licht C; Langlois V
Pediatr Nephrol; 2010 Jul; 25(7):1361-4. PubMed ID: 20145955
[TBL] [Abstract][Full Text] [Related]
4. Hemolytic uremic syndrome due to an altered factor H triggered by neonatal pertussis.
Berner R; Krause MF; Gordjani N; Zipfel PF; Boehm N; Krueger M; Brandis M; Zimmerhackl LB
Pediatr Nephrol; 2002 Mar; 17(3):190-2. PubMed ID: 11956859
[TBL] [Abstract][Full Text] [Related]
5. Hemolytic uremic syndrome with dual caution in an infant: cobalamin C defect and complement dysregulation successfully treated with eculizumab.
Barlas UK; Kıhtır HS; Goknar N; Ersoy M; Akcay N; Sevketoglu E
Pediatr Nephrol; 2018 Jun; 33(6):1093-1096. PubMed ID: 29558000
[TBL] [Abstract][Full Text] [Related]
6. Complement Gene Variants and Shiga Toxin-Producing
Frémeaux-Bacchi V; Sellier-Leclerc AL; Vieira-Martins P; Limou S; Kwon T; Lahoche A; Novo R; Llanas B; Nobili F; Roussey G; Cailliez M; Ulinski T; Deschênes G; Alberti C; Weill FX; Mariani P; Loirat C
Clin J Am Soc Nephrol; 2019 Mar; 14(3):364-377. PubMed ID: 30674459
[TBL] [Abstract][Full Text] [Related]
7. Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors.
Le Clech A; Simon-Tillaux N; Provôt F; Delmas Y; Vieira-Martins P; Limou S; Halimi JM; Le Quintrec M; Lebourg L; Grangé S; Karras A; Ribes D; Jourde-Chiche N; Rondeau E; Frémeaux-Bacchi V; Fakhouri F
Kidney Int; 2019 Jun; 95(6):1443-1452. PubMed ID: 30982675
[TBL] [Abstract][Full Text] [Related]
8. An international consensus approach to the management of atypical hemolytic uremic syndrome in children.
Loirat C; Fakhouri F; Ariceta G; Besbas N; Bitzan M; Bjerre A; Coppo R; Emma F; Johnson S; Karpman D; Landau D; Langman CB; Lapeyraque AL; Licht C; Nester C; Pecoraro C; Riedl M; van de Kar NC; Van de Walle J; Vivarelli M; Frémeaux-Bacchi V;
Pediatr Nephrol; 2016 Jan; 31(1):15-39. PubMed ID: 25859752
[TBL] [Abstract][Full Text] [Related]
9. Hemolytic uremic syndrome with multiple organ involvement secondary to complement factor H p.Arg1215X mutation.
Yeşilbaş O; Şevketoğlu E; Petmezci MT; Kıhtır HS; Benzer M; Berdeli A
Turk J Pediatr; 2017; 59(5):576-580. PubMed ID: 29745120
[TBL] [Abstract][Full Text] [Related]
10. Hemolytic uremic syndrome in an infant following Bordetella pertussis infection.
Pela I; Seracini D; Caprioli A; Castelletti F; Giammanco A
Eur J Clin Microbiol Infect Dis; 2006 Aug; 25(8):515-7. PubMed ID: 16871374
[TBL] [Abstract][Full Text] [Related]
11. Atypical hemolytic uremic syndrome.
Kavanagh D; Goodship TH; Richards A
Semin Nephrol; 2013 Nov; 33(6):508-30. PubMed ID: 24161037
[TBL] [Abstract][Full Text] [Related]
12. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
Mannucci PM; Cugno M
Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
[TBL] [Abstract][Full Text] [Related]
13. Neonatal atypical hemolytic uremic syndrome from a factor H mutation treated with eculizumab.
Sharma S; Pradhan M; Meyers KE; Le Palma K; Laskin BL
Clin Nephrol; 2015 Sep; 84(3):181-5. PubMed ID: 25816809
[TBL] [Abstract][Full Text] [Related]
14. Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.
Brocklebank V; Johnson S; Sheerin TP; Marks SD; Gilbert RD; Tyerman K; Kinoshita M; Awan A; Kaur A; Webb N; Hegde S; Finlay E; Fitzpatrick M; Walsh PR; Wong EKS; Booth C; Kerecuk L; Salama AD; Almond M; Inward C; Goodship TH; Sheerin NS; Marchbank KJ; Kavanagh D
Kidney Int; 2017 Nov; 92(5):1261-1271. PubMed ID: 28750931
[TBL] [Abstract][Full Text] [Related]
15. Ockham's razor defeated: about two atypical cases of hemolytic uremic syndrome.
Schwarz C; Brehon A; Mousseaux C; Luque Y; Senet P; Mariani P; Mohamadou I; Zafrani L; Frémeaux-Bacchi V; Rondeau E; Buob D; Rafat C
BMC Nephrol; 2020 Jul; 21(1):269. PubMed ID: 32652955
[TBL] [Abstract][Full Text] [Related]
16. Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report.
Sevinc M; Basturk T; Sahutoglu T; Sakaci T; Koc Y; Ahbap E; Akgol C; Kara E; Brocklebank V; Goodship TH; Kavanagh D; Unsal A
J Med Case Rep; 2015 Apr; 9():92. PubMed ID: 25925370
[TBL] [Abstract][Full Text] [Related]
17. Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.
Westra D; Volokhina EB; van der Molen RG; van der Velden TJ; Jeronimus-Klaasen A; Goertz J; Gracchi V; Dorresteijn EM; Bouts AH; Keijzer-Veen MG; van Wijk JA; Bakker JA; Roos A; van den Heuvel LP; van de Kar NC
Pediatr Nephrol; 2017 Feb; 32(2):297-309. PubMed ID: 27718086
[TBL] [Abstract][Full Text] [Related]
18. Haemolytic uraemic syndrome associated with non shiga toxin-producing Escherichia coli bacteraemia: a case report.
Bally S; Fourcade J; Frémeaux-Bacchi V
BMC Nephrol; 2019 May; 20(1):157. PubMed ID: 31064333
[TBL] [Abstract][Full Text] [Related]
19. Innovative therapeutic approach: sequential treatment with plasma exchange and eculizumab in a pregnant woman affected by atypical hemolytic-uremic syndrome.
Mussoni MP; Veneziano FA; Boetti L; Tassi C; Calisesi C; Nucci S; Rigotti A; Panzini I; Ardissino G
Transfus Apher Sci; 2014 Oct; 51(2):134-6. PubMed ID: 25294113
[TBL] [Abstract][Full Text] [Related]
20. Atypical HUS due to factor H antibodies in an adult patient successfully treated with eculizumab.
Green H; Harari E; Davidovits M; Blickstein D; Grossman A; Gafter U; Gafter-Gvili A
Ren Fail; 2014 Aug; 36(7):1119-21. PubMed ID: 24828571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
